# Bone Biologics (BBLG) — Earnings

BBLG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bblg/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.33 |
| EPS estimate | −$0.58 |
| EPS surprise | −129.31% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1419554/000149315225011993/form10-q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$0.58 | −$1.33 | -129.31% | — | — |
| Q1 2025 | May 12, 2025 | −$3.24 | −$0.32 | 90.12% | — | — |
| Q1 2024 | May 14, 2024 | −$7.86 | −$7.86 | 0.00% | — | — |
| Q4 2023 | Feb 21, 2024 | −$282.72 | −$35.34 | 87.50% | — | — |
| Q3 2023 | Nov 14, 2023 | −$29.28 | −$29.28 | 0.00% | — | — |
| Q2 2023 | Aug 14, 2023 | −$81.12 | −$81.12 | 0.00% | — | — |
| Q1 2022 | May 13, 2022 | −$288.00 | −$100.80 | 65.00% | — | — |

## Frequently Asked Questions

### When did Bone Biologics (BBLG) last report earnings?

Bone Biologics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did BBLG beat earnings estimates?

No. Bone Biologics reported EPS of −$1.33 for Q2 2025 against a −$0.58 estimate — a 129.31% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).